The Asia-Pacific proteomics market is projected to reach USD 6.96 billion by 2021, growing at a CAGR of 15.31% during the forecast period from 2016 to 2021.
Proteomics involves a complete analysis of proteins in complex biological samples. It has evolved as an exciting but challenging discipline. The invention of Mass Spectrometry (MS) has revolutionized the study of proteomics. Continuous improvisation of MS instrumentation has enabled the researchers for better analysis of the proteome. The application of MS is not limited to proteome analysis but also extends to metabolites, lipids, carbohydrates, and metals, among others. One of the remarkable achievements in proteomics was combining liquid chromatography systems with MS.
The market is driven by the increased R&D activities in the proteomics field, increased government and private funding for proteomics, and increased technological innovations for the purification and extraction of proteins. However, the market has been witnessing some major restraints, such as the high cost of equipment and strict regulatory norms that make approval of the process of proteomic technology costly and lengthy.
In this report, the market is segmented by instrumentation technology, services market, application, and geography. The instrumentation technology segment is further segmented into protein microarray, spectroscopy, X-ray crystallography, chromatography, electrophoresis, and others. The services segment is further segmented into analytical laboratory services and data analysis & maintenance. The application segment is further segmented into drug discovery, clinical diagnosis, and others. By geography, the market has been divided into India, China, and Japan.
This market is dominated by the protein microarray segment, which accounts for almost half of the market share, followed by the spectroscopy segment, which holds 35.0% of the market share. The two major categories of protein microarrays that are currently available in the market are analytical and functional protein microarrays. Functional protein microarrays are increasingly applied to many areas of drug discovery. Analytical protein microarrays, which are mostly antibody microarrays, are the most commonly used multiplexed detection technologies.
Some of the key players in the market are:
Key Deliverables in the Study
Looking to Customize Report?